PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2015

Combinatorial resveratrol and quercetin polymeric micelles mitigate doxorubicin induced cardiotoxicity in vitro and in vivo.

Mixed / Chemical/toxin

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 26160305 ↗2015Reported benefit

Combinatorial resveratrol and quercetin polymeric micelles mitigate doxorubicin induced cardiotoxicity in vitro and in vivo.

MixedChemical/toxinResveratrol to quercetin to doxorubicin ratio of 10:10:1; m…Co-administered concurrently with doxorubicin

Model: Acute doxorubicin hydrochloride-induced cardiotoxicity in healthy mice

The 10:10:1 resveratrol:quercetin:doxorubicin combination was synergistic in ovarian cancer cells and antagonistic in cardiomyocytes, scavenging reactive oxygen species and reducing caspase 3/7 activity only in cardiomyocytes. In mice, co-administration of the micelles with acute doxorubicin confer…

Extraction: extract · Supplied extraction confidence: 0.6. Machine-extracted fields require source verification.